Biochemical hallmarks of tyrosine hydroxylase deficiency

Clinical Chemistry

Volumn 44, Issue 9, 1998, Pages 1897-1904

  Bräutigam, Christa ^a   Wevers, Ron A ^b   Jansen, Riet J T ^b   Smeitink, Jan A M ^b   De Rijk van Andel, Johanneke F ^c   Gabreëls, Fons J M ^b   Hoffmann, Georg F ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Ignatius Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TYROSINE 3 MONOOXYGENASE;

ARTICLE; CASE REPORT; CATECHOLAMINE SYNTHESIS; CLINICAL PROTOCOL; DIAGNOSTIC VALUE; DYSTONIA; ENZYME DEFICIENCY; HUMAN; LUMBAR PUNCTURE; NETHERLANDS; POINT MUTATION;

ADOLESCENT; AGE FACTORS; BIOLOGICAL MARKERS; CARBIDOPA; CHILD; CHILD, PRESCHOOL; DOPAMINE AGENTS; DRUG THERAPY, COMBINATION; DYSTONIA; FEMALE; HUMANS; INFANT; LEVODOPA; MALE; REFERENCE VALUES; SPECIMEN HANDLING; TYROSINE 3-MONOOXYGENASE;

EID: 0031721663     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cooper JR, Bloom FE, Roth RH. The biochemical basts of neuropharmacology. New York: Oxford University Press, 1996:230pp.
2. Kopin IJ, Gordon EK, Jimerson DC, Polinsky RJ. Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol. Science 1983;219:73-5.
3. Ichinose H, Ohye T, Takahshi E, Seki N, Hori T, Segawa M, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994;8:236-42.
4. Clayton PT, Heales SJR, Brand M, Clelland J, Suttees RJ. An infant with clinical features, a metabolic profile to treatment suggestive of tyrosine hydroxylase deficiency. Poster presentation 49, 32nd Annu. Symp. Society for the Study of Inborn Errors of Metablism, Edinburgh, 1994.
5. Lüdecke B, Dworniczak B, Bartholomé K. A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum Genet 1995;95:123-5.
6. Knappskog PM, Flatmark T, Mallet J, Lüdecke B, Bartholomé K. Recessively inherited L-dopa-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet 1995;4:1209-12.
7. Lüdecke B, Knappskog PM, Clayton PT, Surtees RAH, Clelland JD, Heales SJR, et al. Recessively inherited L-dopa-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum Mol Genet 1996;5:1023-8.
8. van den Heuvel LPWJ, Luiten B, Smeitink JAM, de Rijk-van Andel JF, Steenbergen-Spanjers GCH, Jansen RJT, et al. A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-dopa responsive dystonia (DRD) in the Dutch population. Hum Genet (in press).
9. Westerink BHC, Mulder TBA. Determination of picomole amounts of dopamine, noradrenaline, 3,4-dihydroxyphenylalanine, 3,4-dihydroxphenylacetic acid, homovanillic acid, and 5-hydroxyindolacetic acid in nervous tissue after one-step purification on Sephadex G-10, using high-performance liquid chromatography with a novel type of electrochemical detection. J Neurochem 1981;36:1449-62.
10. Hyland K, Surtees RAH, Rodeck C, Clayton PT. Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis. Neurology 1992;42:1980-8.
11. Gerrits GP, Trijbels FJ, Monnens LA, Gabreëls FJ, de Abreu RA, Theeuwes AdG, et al. Reference values for amino acids in cerebrospinal fluid of children determined using ion-exchange chromatography with fluorimetric detection. Clin Chim Acta 1989; 182:271-80.
12. Anderson GM, Hoder EL, Shaywitz BA, Cohen DJ. Neurotransmitter precursors and metabolites in CSF of human neonates. Dev Med Child Neurol 1985;27:207-14.
13. Hyland K, Surtees RAH, Heales SJR, Bowron A, Howells DW, Smith I. Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population. Pediatr Res 1993;34:10-4.
14. Langlais PJ, Walsh FX, Bird ED, Levy HL. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children. Pediatrics 1985;75:580-6.
15. Seifert WE, Foxx JL, Butler IJ. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid. Ann Neurol 1979;8:38-42.
16. Sjöström R, Ekstedt J, Änggård E. Concentration gradients of monoamine metabolites in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1975;38:666-8.
17. Kruesi MJP, Swedo SE, Hamburger SD, Potter WZ, Rapoport JL. Concentration gradient of CSF monoamine metabolites in children and adolescents. Biol Psychiatry 1988;24:507-14.
18. Langlais PJ, Bird ED, McEntee WJ. Stability of monoamine metabolites in human cerebrospinal fluid. Ann Neurol 1981;12:48-51.
19. Davidson L, Van dongen R, Beilin LJ. Effect of eating bananas on plasma free and sulfate-conjugated catecholamines. Life Sci 1981;29:1773-8.
20. Mashige F, Matsushima Y, Kanazawa H, Sakuma I, Takai N, Bessho F, et al. Acidic catecholamine metabolites and 5-hydroxyindolacetic acid in urine: the influence of diet. Ann Clin Biochem 1996;33:43-9.
21. Sandler M, Uthven CRJ. The biosynthesis and metabolism of the catecholamines. Progr Med Chem 1969:200-46.